Clinuvel Pharmaceuticals Limited's market cap is currently ―. The company's EPS TTM is $0.405; its P/E ratio is 24.07; and it has a dividend yield of 0.35%. Clinuvel Pharmaceuticals Limited is scheduled to report earnings on August 28, 2024, and the estimated EPS forecast is $0.29. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 22	Jun 21	Jun 20	Jun 19	Jun 18
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	-	-	-	-	-
EBITDA	-	-	-	-	-
Net Income Common Stockholders	-	-	-	-	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	AU$ 121.51M	AU$ 82.69M	AU$ 66.75M	AU$ 54.27M	AU$ 36.20M
Total Assets	AU$ 143.95M	AU$ 108.57M	AU$ 81.54M	AU$ 62.35M	AU$ 42.90M
Total Debt	AU$ 1.26M	AU$ 1.30M	AU$ 1.32M	AU$ 432.52K	AU$ 0.00
Net Debt	AU$ -120.25M	AU$ -81.39M	AU$ -65.43M	AU$ -53.84M	AU$ -36.20M
Total Liabilities	-	AU$ 9.83M	AU$ 7.87M	AU$ 5.17M	AU$ 3.49M
Stockholders Equity	AU$ 125.56M	AU$ 98.74M	AU$ 73.67M	AU$ 57.18M	AU$ 39.42M
Cash Flow	-
Free Cash Flow	-	-	-	-	-
Operating Cash Flow	-	-	-	-	-
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-	-	-	-	-

Currency in AUD

Clinuvel Pharmaceuticals Limited Earnings and Revenue History

Income Statement >

Clinuvel Pharmaceuticals Limited Debt to Assets

Balance Sheet >

Clinuvel Pharmaceuticals Limited Cash Flow

Cash Flow >

Clinuvel Pharmaceuticals Limited Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing